Labisan
NDC Package 72892-932-72

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Labisan is directionsClean the affected area at first sign of tingling, burning sensation, or itching.Apply a small amount of this product to the lips or nose prior to exposure to the sun.In case of cold sore/fever blister indication, apply to area of sensation.Apply up to 4 times a day, and in the evening.Rub in gently.Wash hands before and after applying cream.Do not share product with anyone.Keep out of reach of children.Children under 12 years of age: Consult a physician. Marketed by Labisan Americas, Llc., this product is identified by NDC 72892-932 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
72892-932-72
Package Description
6.7 mg in 1 TUBE
Product Code
72892-932
11-Digit Billing Format
72892093272
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Labisan
Dosage Form
-
Usage Information
DirectionsClean the affected area at first sign of tingling, burning sensation, or itching.Apply a small amount of this product to the lips or nose prior to exposure to the sun.In case of cold sore/fever blister indication, apply to area of sensation.Apply up to 4 times a day, and in the evening.Rub in gently.Wash hands before and after applying cream.Do not share product with anyone.Keep out of reach of children.Children under 12 years of age: Consult a physician.

Regulatory & Marketing

Labeler Name
Labisan Americas, Llc.
FDA Application #
part347
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-22-2019
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72892-932-72 identifies a specific commercial package of 6.7 mg in 1 tube of Labisan, labeled by Labisan Americas, Llc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Labisan Americas, Llc. on February 22, 2019. The current certification is valid through December 31, 2021.

How is this Labisan Americas, Llc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72892093272. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72892-932-72
11-Digit CMS (5-4-2)
72892-0932-72

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.